Research on sleep disorders in multiple sclerosis (MS) patients reveals a complex and significant relationship that profoundly affects their quality of life, symptom severity, and disease progression. Sleep disturbances are notably more common in people with MS than in the…
Histamine plays a multifaceted role in the progression of multiple sclerosis (MS), primarily through its involvement in immune regulation, inflammation, and blood-brain barrier (BBB) dynamics. MS is an autoimmune disease characterized by chronic inflammation and demyelination within the central nervous…
Short-chain fatty acids (SCFAs) play a crucial role in the complex interactions between the gut microbiota and the immune system, which is especially important in diseases like multiple sclerosis (MS). MS is an autoimmune disorder where the immune system mistakenly…
Multiple sclerosis (MS) is a complex neurological disease that affects the central nervous system, causing symptoms like muscle weakness, vision problems, and difficulties with coordination and balance. While the exact cause of MS remains unknown, recent research has uncovered a…
Fecal microbiota transplantation (FMT) is an emerging area of research that involves transferring stool from a healthy donor into the gastrointestinal tract of a patient, with the goal of restoring a balanced gut microbiome. In recent years, scientists have been…
The **microbiome**, particularly the gut microbiome, plays a significant and complex role in the relapses experienced by people with multiple sclerosis (MS). MS is an autoimmune disease where the immune system mistakenly attacks the protective covering of nerve fibers in…
Multiple sclerosis (MS) is a complex neurological condition characterized by the immune system attacking the protective covering of nerve fibers in the central nervous system. This leads to symptoms such as muscle weakness, fatigue, and problems with coordination and vision.…
Multiple sclerosis (MS) is a chronic neurological disease characterized by the immune system attacking the protective covering of nerves, leading to inflammation and damage in the brain and spinal cord. This causes symptoms like muscle weakness, vision problems, fatigue, and…
The research on antivirals targeting Epstein-Barr virus (EBV) in multiple sclerosis (MS) is an emerging and rapidly evolving field, driven by compelling evidence that EBV infection plays a crucial role in the development and progression of MS. Scientists have long…
The role of early antibiotics in the development of multiple sclerosis (MS) is a complex and emerging area of research that revolves largely around how antibiotics affect the gut microbiota during critical periods of immune and neurological development. MS is…